Regeneron Pharmaceuticals Stock Price on December 31, 2022
| REGN Stock | USD 1,006 12.58 1.27% |
Below is the normalized historical share price chart for Regeneron Pharmaceuticals extending back to April 02, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Regeneron Pharmaceuticals stands at 1,006, as last reported on the 6th of June, with the highest price reaching 1,015 and the lowest price hitting 989.77 during the day.
If you're considering investing in Regeneron Stock, it is important to understand the factors that can impact its price. We consider Regeneron Pharmaceuticals very steady. Regeneron Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0653, which implies the firm had a 0.0653% return per unit of risk over the last 3 months. We have found thirty technical indicators for Regeneron Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Regeneron Pharmaceuticals' Coefficient Of Variation of 1693.04, risk adjusted performance of 0.0407, and Semi Deviation of 0.887 to confirm if the risk estimate we provide is consistent with the expected return of 0.0655%.
At this time, Regeneron Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 6th of June 2024, Liabilities And Stockholders Equity is likely to grow to about 34.7 B, while Common Stock Shares Outstanding is likely to drop about 75.4 M. . At this time, Regeneron Pharmaceuticals' Price Fair Value is very stable compared to the past year. Regeneron Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of April 1991 | 200 Day MA 891.2675 | 50 Day MA 946.4972 | Beta 0.168 |
Regeneron |
Sharpe Ratio = 0.0653
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | REGN | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.0 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Regeneron Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regeneron Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 3.8232 | Enterprise Value Ebitda 19.4231 | Price Sales 7.5703 | Shares Float 103.3 M | Wall Street Target Price 1.1 K |
Regeneron Pharmaceuticals Valuation on December 31, 2022
It is possible to determine the worth of Regeneron Pharmaceuticals on a given historical date. On December 31, 2022 Regeneron was worth 721.16 at the beginning of the trading date compared to the closed value of 721.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Regeneron Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Regeneron Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regeneron Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Regeneron Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 717.00 | 728.09 | 710.36 | 721.29 | 415,311 | |
12/30/2022 | 721.16 | 722.16 | 710.25 | 721.49 | 351,163 |
| 721.86 | 732.43 | 719.35 | 720.47 | 450,086 |
| Backtest Regeneron Pharmaceuticals | | | Regeneron Pharmaceuticals History | | | Regeneron Pharmaceuticals Valuation | Previous | Next |
Regeneron Pharmaceuticals Trading Date Momentum on December 31, 2022
| On January 03 2023 Regeneron Pharmaceuticals was traded for 720.47 at the closing time. The top price for the day was 732.43 and the lowest listed price was 719.35 . The trading volume for the day was 450.1 K. The trading history from January 3, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.14% . The trading delta at closing time against the current closing price is 3.93% . |
Regeneron Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Regeneron Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Regeneron Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Regeneron financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Regeneron Pharmaceuticals Stock history
Regeneron Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regeneron is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regeneron Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regeneron Pharmaceuticals stock prices may prove useful in developing a viable investing in Regeneron Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 113.7 M | 75.4 M | |
| Net Income Applicable To Common Shares | 5 B | 5.2 B |
Regeneron Pharmaceuticals Quarterly Net Working Capital |
|
Regeneron Pharmaceuticals Stock Technical Analysis
Regeneron Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Regeneron Pharmaceuticals Period Price Range
Low | December 30, 2022
| High |
721.16 | 721.49 |
Regeneron Pharmaceuticals June 6, 2024 Market Strength
Market strength indicators help investors to evaluate how Regeneron Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regeneron Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Regeneron Pharmaceuticals stock market strength indicators, traders can identify Regeneron Pharmaceuticals entry and exit signals to maximize returns
| Accumulation Distribution | 5791.45 | |||
| Daily Balance Of Power | 0.0277 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 716.21 | |||
| Day Typical Price | 717.97 | |||
| Price Action Indicator | 5.45 | |||
| Period Momentum Indicator | 284.38 | |||
| Relative Strength Index | 61.58 |
Regeneron Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Regeneron Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Regeneron Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regeneron to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0407 | |||
| Jensen Alpha | 0.0338 | |||
| Total Risk Alpha | 0.0213 | |||
| Sortino Ratio | 0.0329 | |||
| Treynor Ratio | 0.0579 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Information and Resources on Investing in Regeneron Stock
When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Earnings Share 33.87 | Revenue Per Share 122.574 | Quarterly Revenue Growth (0.01) | Return On Assets 0.0774 |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.